Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Solutions (RSSS) Current Deferred Revenue (2016 - 2025)

Research Solutions (RSSS) has disclosed Current Deferred Revenue for 15 consecutive years, with $9.9 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 12.01% to $9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.9 million through Dec 2025, up 12.01% year-over-year, with the annual reading at $10.7 million for FY2025, 0.0% changed from the prior year.
  • Current Deferred Revenue for Q4 2025 was $9.9 million at Research Solutions, down from $10.0 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $10.7 million in Q2 2024, with the low at $4.4 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $7.3 million, with a median of $6.5 million recorded in 2023.
  • The sharpest move saw Current Deferred Revenue soared 66.58% in 2024, then changed 0.0% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $4.7 million in 2021, then increased by 25.86% to $6.0 million in 2022, then skyrocketed by 31.44% to $7.8 million in 2023, then rose by 12.87% to $8.9 million in 2024, then increased by 12.01% to $9.9 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $9.9 million, $10.0 million, and $10.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.